Orgasmiin

Orgasmiin is a fictional psychoactive compound described in speculative pharmacology and science fiction. It is not approved for medical use and has no verified presence in real-world pharmacopoeias. The name derives from reported enhancements to sensory and affective experiences in fictional accounts.

In the fiction and speculative literature, orgasmiin is described as a small-molecule amine with a phenethylamine-like core. It is usually depicted as a serotonergic agent, acting as a partial agonist at the 5-HT2A receptor and as a reuptake inhibitor for serotonin and dopamine to varying degrees. In these narratives, this combination can produce mood elevation, perceptual enhancement, and increased sociability, alongside potential risks such as anxiety, neurotoxicity, and dependence in extended use.

Chemistry and production: Orgasmiin is typically portrayed as a synthetically produced compound with several ring substituents that modulate receptor affinity. No validated synthesis or stability data exists in credible scientific sources because the compound is fictional.

Regulation and reception: Because orgasmiin is fictional, it has no legal status in real-world jurisdictions. The concept is used in fiction and discussion to explore ethical questions around psychoactive research, regulatory oversight, and the social implications of neuroactive drugs.